Framing Public Health and Pharmacy

Author(s):  
Ardis Hanson ◽  
Bruce Lubotsky Levin ◽  
Peter D. Hurd

This chapter incorporates a number of global perspectives of pharmacy and public health, including international perspectives (e.g., World Health Organization, macro-level), regional perspectives (e.g., European Union, meso-level), and national (e.g., country, micro-level) perspectives. This chapter provides a broader understanding of how issues in pharmacy and public health are framed and reframed as the field moves from a national understanding of pharmacy and public health to broader regional and global understandings. It also shows show there are significant commonalities and differences in the practice, education, and research in the disciplines and careers of pharmacy and public health. Topics covered include integrated delivery of health care, preventive health services, public–private sector partnerships, global health, public health engagement, public health surveillance, public health practice, and public health systems research.

Author(s):  
Mythri Halappa

AbstractMedications are one of the most important tools in public health practice. Since the 1980s, self‑medication is of prime public health importance as World Health Organization, in order to reduce the burden on health care professionals changed some prescription drugs to be sold over the counter. Each drug has its own advantages & disadvantages. Hence, always they have to be taken with caution. Considering this a recent trend has increased in surveying the prevalence of self medication. Hence, this review critically evaluated the studies to put a light on basic concept of self medication.Key words: Self medication, Drug abuse, Self care, Substance abuse, Antibiotic usage. 


2020 ◽  
Vol 24 (5) ◽  
pp. 9-14
Author(s):  
R. Bayer ◽  
A. L. Fairchild ◽  
M. Zignol ◽  
K. G. Castro

In June 2017, the World Health Organization issued the Guidelines on Ethical Issues in Public Health Surveillance. Using the frame of public health ethics, the guidance declared that countries have an affirmative duty to undertake surveillance and that the global community had an obligation to support those countries whose resources limited their capacity. The centrality of TB surveillance has long been recognized as a matter of public health practice and ethics. Nevertheless, contemporary global realities make clear that TB surveillance falls far short of the goal of uniform notification. It is this reality that necessitated the paradoxical turn to research studies that require informed consent and human subjects' ethical review, the very burdens that mandated notification were designed to overcome.


2003 ◽  
Vol 7 (21) ◽  
Author(s):  
P Horby

The first global consultation on the epidemiology of severe acute respiratory syndrome (SARS) took place in Geneva on 16 and 17 May (http://www.who.int/csr/sars/archive/2003_05_17/en/). The purpose of the meeting was to ensure that the World Health Organization (WHO) recommendations are based on the best available scientific evidence and to review the available epidemiological information in the context of its relevance to effective public health practice. Sixteen countries, including all those most affected by SARS, were represented either in person, by video link, or by telephone. A number of experts in the mathematical modelling of infectious diseases were also present.


1989 ◽  
Vol 102 (2) ◽  
pp. 199-204 ◽  
Author(s):  
P. S. Brachman ◽  
S. I. Music

There is a significant role for the practice of epidemiology throughout the world if health professionals are to work effectively towards ‘Health for All’. The status quo leaves a great deal to be desired, as evidenced by recent signals from the premier international health agency, the World Health Organization (WHO). The forty-first World Health Assembly meeting in Geneva, Switzerland, in May 1988 approved a resolution stressing ‘the importance of epidemiology as a tool for the formulation of rational health policy’ (PAHO, 1988). In addition to its key role ‘in studying the causes and means of prevention of disease’, the Assembly noted epidemiology's valuable inputs in ‘health systems research, information support, technology assessment, and the management and evaluation of health service’.


2021 ◽  

Intersectoral collaboration has become an essential dimension of public health practice and policy since the mid-1970s. This article reviews the origins, theories, alternate views, and evidence, as well as guidance and training documents pertinent to this field. Although there were some antecedents of intersectoral thinking in the 1970s—for example, World Health Organization, National Environmental Health Programmes: Their Planning, Organization, and Administration; Report of a WHO Expert Committee (Meeting Held in Geneva from 3 to 11 June 1969), World Health Organization Technical Report 439 (Geneva, Switzerland: World Health Organization, 1970)—the heyday of conceptual and rhetorical development fell in the 1980s. The World Health Organization convened expert meetings—for example, Morris Schaefer, Intersectoral Cooperation and Health in Environmental Management: An Examination of National Experience (Geneva, Switzerland: World Health Organization, 1981)—and issued authoritative inventories of the success of intersectoral action—for example, World Health Organization, Intersectoral Action for Health: The Role of Intersectoral Cooperation in National Strategies for Health for All (Geneva, Switzerland: World Health Organization, 1986). This experience, and subsequent calls for further action and policymaking, culminated in a standard of setting conferences where key principles and dimensions of intersectoral action were affirmed; for example, W. Kreisel and Y. von Schirnding, “Intersectoral Action for Health: A Cornerstone for Health for All in the 21st Century,” World Health Statistics Quarterly / Rapport trimestriel de statistiques sanitaires mondiales 51.1 (1998): 75–78. Here, we combine insights from public health, political science, sociology, and public administration to comprehensively map the current body of knowledge.


Author(s):  
Katherine Cullerton ◽  
Jean Adams ◽  
Martin White

The issue of public health and policy communities engaging with food sector companies has long caused tension and debate. Ralston and colleagues’ article ‘Towards Preventing and Managing Conflict of Interest in Nutrition Policy? An Analysis of Submissions to a Consultation on a Draft WHO Tool’ further examines this issue. They found widespread food industry opposition, not just to the details of the World Health Organization (WHO) tool, but to the very idea of it. In this commentary we reflect on this finding and the arguments for and against interacting with the food industry during different stages of the policy process. While involving the food industry in certain aspects of the policy process without favouring their business goals may seem like an intractable problem, we believe there are opportunities for progress that do not compromise our values as public health professionals. We suggest three key steps to making progress.


Coronaviruses ◽  
2020 ◽  
Vol 01 ◽  
Author(s):  
Chandra Mohan ◽  
Vinod Kumar

: World Health Organization (WHO) office in China received the information of pneumonia cases of unknown aetiology from Wuhan, central China on 31st December 2019, subsequently this disease spreading in china and rest of world. Till the March 2020 end, more than 2 lakhs confirmed cases with more than 70000 deaths were reported worldwide, very soon researchers identified it as novel beta Corona virus (virus SARS-CoV-2) and its infection coined as COVID-19. Health ministries of various countries and WHO together fighting to this health emergency, which not only affects public health, but also started affecting various economic sectors as well. The main aim of the current article is to explore the various pandemic situations (SARS, MERS) in past, life cycle of COVID-19, diagnosis procedures, prevention and comparative analysis of COVID-19 with other epidemic situations.


2021 ◽  
Vol 29 (Supplement_1) ◽  
pp. i45-i46
Author(s):  
A Peletidi ◽  
R Kayyali

Abstract Introduction Obesity is one of the main cardiovascular disease (CVD) risk factors.(1) In primary care, pharmacists are in a unique position to offer weight management (WM) interventions. Greece is the European country with the highest number of pharmacies (84.06 pharmacies per 100,000 citizens).(2) The UK was chosen as a reference country, because of the structured public health services offered, the local knowledge and because it was considered to be the closest country to Greece geographically, unlike Australia and Canada, where there is also evidence confirming the potential role of pharmacists in WM. Aim To design and evaluate a 10-week WM programme offered by trained pharmacists in Patras. Methods This WM programme was a step ahead of other interventions worldwide as apart from the usual measuring parameters (weight, body mass index, waist circumference, blood pressure (BP)) it also offered an AUDIT-C and Mediterranean diet score tests. Results In total,117 individuals participated. Of those, 97.4% (n=114), achieved the programme’s aim, losing at least 5% of their initial weight. The mean % of total weight loss (10th week) was 8.97% (SD2.65), and the t-test showed statistically significant results (P<0.001; 95% CI [8.48, 9.45]). The programme also helped participants to reduce their waist-to-height ratio, an early indicator of the CVD risk in both male (P=0.004) and female (P<0.001) participants. Additionally, it improved participants’ BP, AUDIT-C score and physical activity levels significantly (P<0.001). Conclusion The research is the first systematic effort in Greece to initiate and explore the potential role of pharmacists in public health. The successful results of this WM programme constitute a first step towards the structured incorporation of pharmacists in public’s health promotion. It proposed a model for effectively delivering public health services in Greece. This study adds to the evidence in relation to pharmacists’ CVD role in public health with outcomes that superseded other pharmacy-led WM programmes. It also provides the first evidence that Greek pharmacists have the potential to play an important role within primary healthcare and that after training they are able to provide public health services for both the public’s benefit and their clinical role enhancement. This primary evidence should support the Panhellenic Pharmaceutical Association, to “fight” for their rights for an active role in primary care. In terms of limitations, it must be noted that the participants’ collected data were recorded by pharmacists, and the analysis therefore depended on the accuracy of the recorded data, in particular on the measurements or calculations obtained. Although the sample size was achieved, it can be argued that it is small for the generalisation of findings across Greece. Therefore, the WM programme should be offered in other Greek cities to identify if similar results can be replicated, so as to consolidate the contribution of pharmacists in promoting public health. Additionally, the study was limited as it did not include a control group. Despite the limitations, our findings provide a model for a pharmacy-led public health programme revolving around WM that can be used as a model for services in the future. References 1. Mendis S, Puska P, Norrving B, World Health Organization., World Heart Federation., World Stroke Organization. Global atlas on cardiovascular disease prevention and control [Internet]. Geneva: World Health Organization in collaboration with the World Heart Federation and the World Stroke Organization; 2011 [cited 2018 Jun 26]. 155 p. Available from: http://www.who.int/cardiovascular_diseases/publications/atlas_cvd/en/ 2. Pharmaceutical Group of the European Union. Pharmacy with you throughout life:PGEU Annual Report [Internet]. 2015. Available from: https://www.pgeu.eu/en/library/530:annual-report-2015.html


2020 ◽  
pp. 1-11
Author(s):  
Robin ROOM ◽  
Jenny CISNEROS ÖRNBERG

This article proposes and discusses the text of a Framework Convention on Alcohol Control, which would serve public health and welfare interests. The history of alcohol’s omission from current drug treaties is briefly discussed. The paper spells out what should be covered in the treaty, using text adapted primarily from the Framework Convention on Tobacco Control, but for the control of trade from the 1961 narcotic drugs treaty. While the draft provides for the treaty to be negotiated under the auspices of the World Health Organization, other auspices are possible. Excluding alcohol industry interests from the negotiation of the treaty is noted as an important precondition. The articles in the draft treaty and their purposes are briefly described, and the divergences from the tobacco treaty are described and justified. The text of the draft treaty is provided as Supplementary Material. Specification of concrete provisions in a draft convention points the way towards more effective global actions and agreements on alcohol control, whatever form they take.


Sign in / Sign up

Export Citation Format

Share Document